| Unique ID issued by UMIN | UMIN000061437 |
|---|---|
| Receipt number | R000070297 |
| Scientific Title | A study to evaluate the safety of excessive consumption of the test food |
| Date of disclosure of the study information | 2026/05/01 |
| Last modified on | 2026/05/01 19:45:51 |
A study to evaluate the safety of excessive consumption of the test food
A study to evaluate the safety of excessive consumption of the test food
A study to evaluate the safety of excessive consumption of the test food
A study to evaluate the safety of excessive consumption of the test food
| Japan |
Healthy Adults
| Adult |
Others
NO
To evaluate the safety of excessive consumption of the test food.
Safety
Adverse events
Physical examination, blood tests, urine tests
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
YES
NO
YES
No need to know
2
Prevention
| Food |
Oligonol1 g/day,10 cupsiles/day,4 weeks
Placebo (Dextrin), 10 capsules/day for 4 weeks
| 25 | years-old | <= |
| 65 | years-old | > |
Male and Female
1.Individuals with a BMI of 22.0 kg/m2 or higher but less than 30.0 kg/m2
2.Men and women aged 25 to 64
3.Individuals who have provided written consent to participate in this study
1.Individuals for whom participation in the trial is difficult due to liver, kidney, or heart disease; respiratory disorders; endocrine disorders; metabolic disorders; neurological disorders; impaired consciousness; diabetes; or other medical conditions
2.Individuals who have undergone surgery or received medication for an illness or injury within two months prior to the start of this trial
3.Individuals currently taking medications to improve glucose metabolism, lipid metabolism, or blood pressure
4.Individuals who regularly consume foods for specific health uses or foods with functional claims (however, this does not apply to those who can suspend consumption during the trial period at the time of obtaining the consent form)
5.Individuals who are unable to consume the test food
6.Individuals who may exhibit allergic reactions to ingredients contained in the test food
7.Individuals currently participating in another clinical trial or planning to participate in one during the duration of this trial
8.Individuals who do not agree with the purpose of this trial as explained in the pre-trial briefing
9.Individuals who are pregnant or breastfeeding, or who plan to become pregnant or breastfeed during the trial period
10.Any other individuals whom the principal investigator deems unsuitable from the perspective of ensuring subject safety, based on data from health examinations or other sources
30
| 1st name | Ryuji |
| Middle name | |
| Last name | Takeda |
Kansai University of Welfare Sciences
Department of Nutritional Sciences for Welll-being Faculty of Health Science for Welfare
582-0026
Asahigaoka 3-11-1, Kashiwara, Osaka
072-978-0088
rtakeda@tamateyama.ac.jp
| 1st name | Shigenori |
| Middle name | |
| Last name | Nibun |
EAS inc.
Clinical Trial Session
236-0028
Susaki-Cho1-10-2F, Kanazawa-ku, Yokohama city, Kanagawa
045-374-3392
info@eas-ct.jp
Amino Up Co., Ltd.
Amino Up Co.,Ltd.
Profit organization
Japan
KOBUNA ORTHOPEDIC SURGERY
311-2, Gokan-machi, Maebashi, Gunma
027-261-7600
info@kobunaseikei.jp
NO
| 2026 | Year | 05 | Month | 01 | Day |
Unpublished
Preinitiation
| 2026 | Year | 03 | Month | 10 | Day |
| 2026 | Year | 03 | Month | 19 | Day |
| 2026 | Year | 05 | Month | 07 | Day |
| 2026 | Year | 10 | Month | 31 | Day |
| 2026 | Year | 05 | Month | 01 | Day |
| 2026 | Year | 05 | Month | 01 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000070297